In November 2025, LEGALBAND officially released its annual list, "China Top 15 Lawyers - Healthcare" 2025. Llinks Partner Mr. Yiguang Lu was included in this prestigious ranking, recognizing his exceptional professional capabilities and outstanding project achievements.

Yiguang Lu

Mr. Yiguang Lu graduated from the School of Medicine at Nanjing University and holds Chinese Lawyer qualification. Mr. Lu has long been dedicated to compliance management and dispute resolution in the major healthcare sector (medical, pharmaceutical, and medical insurance), including the legality assessment of major decisions and projects, as well as handling major crises in accordance with the law for medical institutions and pharmaceutical enterprises. He serves as legal counsel for numerous medical institutions, pharmaceutical companies, and law enforcement authorities. Mr. Lu has successively served as Vice-Chairman of the Professional Committee on Medical and Health Law of the All-China Lawyers Association, Expert Consultant on Civil and Administrative Cases for the Supreme People's Procuratorate, Chairman of the Healthcare Professional Committee of the Shanghai Lawyers Association, Chairman of the Administrative Law Professional Committee of the Shanghai Lawyers Association, and Member of the Shanghai Municipal People's Government Administrative Review Committee, among other roles. Mr. Lu is the author of several books, including Practical Legal Risk Management for Medical Institutions and Pharmaceutical Companies, Analysis of Typical Cases in Medical Compliance, and Legal Practice and Typical Cases in Medical Aesthetics. In 2023, Mr. Lu was awarded the honorary title of "Fifth Oriental Distinguished Lawyer."

LEGALBAND's Remark

Mr. Yiguang Lu has dedicated over twenty years to intensive practice in the medical and pharmaceutical fields. Mr. Lu leads a team that provides long-term legal services to health commissions, drug regulatory authorities, various medical institutions, and biomedical enterprises. Mr. Lu's practice covers compliance management in the medical, pharmaceutical, and medical device sectors, as well as related civil and administrative dispute resolution and criminal risk control. Mr. Lu possesses long-term theoretical research and practical business experience in the healthcare industry, including medical services, pharmaceuticals, and medical insurance. He deeply understands the comprehensive compliance requirements and legal demands of companies in this sector across multiple dimensions, such as major decision-making, clinical R&D, product registration and change, post-market circulation and use, medical advertising, anti-unfair competition, and cross-border collaboration. Mr. Lu is thus able to provide comprehensive legal solutions and response strategies—from legal risk management and handling enforcement investigations to dispute resolution—for clients in this sector.

Client's Testimonial

"Mr. Yiguang Lu is professionally robust and reliable in cooperation. With years of experience in the pharmaceutical sector, he can precisely build compliance management systems, especially for non-typical clinical research, balancing risk and efficiency. In litigation concerning adverse events during clinical trials, he skillfully utilizes his 'legal + medical' composite knowledge to formulate defense strategies based on regulations and medical literature, demonstrating rich practical experience. He also conducts in-depth research into cutting-edge areas, providing valuable consultation to our company. He is highly responsive, and his solutions are pragmatic and actionable, offering support from a strategic corporate perspective. He is a long-term partner who balances both professionalism and reliability."

For this selection, LEGALBAND primarily referenced recommendation materials from major law firms, self-nomination submissions from lawyers, and client feedback. This information was combined with the long-term focus and insight of the LEGALBAND China-based research team into the medical and pharmaceutical industries, ultimately selecting 15 of the most highly recommended lawyers in this field across Chinese mainland.